0,921  0,004  Analgesic
0,902  0,004  CYP2D6 substrate
0,810  0,003  NMDA receptor antagonist
0,788  0,002  Antismoking
0,783  0,004  5 Hydroxytryptamine release stimulant
0,769  0,001  NMDA receptor phencyclidine site antagonist
0,760  0,002  NMDA 2C receptor antagonist
0,755  0,005  Dependence treatment
0,745  0,003  Opioid antagonist
0,746  0,005  Antiparkinsonian
0,741  0,003  Analgesic, opioid
0,733  0,002  Opioid agonist
0,718  0,003  Cocaine dependence treatment
0,719  0,004  UGT1A1 substrate
0,714  0,005  Stroke treatment
0,706  0,003  Sigma receptor agonist
0,701  0,003  Opioid mu receptor antagonist
0,688  0,002  NMDA receptor subunit 3A antagonist
0,676  0,005  CYP2D6 inhibitor
0,668  0,002  Opioid mu receptor agonist
0,668  0,003  NMDA 2 receptor antagonist
0,667  0,003  Opioid delta receptor antagonist
0,669  0,009  CYP2C19 substrate
0,654  0,003  UGT2B1 substrate
0,669  0,021  CYP3A4 substrate
0,641  0,002  Opioid kappa receptor antagonist
0,642  0,017  CYP2C9 substrate
0,629  0,006  Antineurogenic pain
0,609  0,015  Antidepressant
0,592  0,005  Acute neurologic disorders treatment
0,588  0,005  Amyotrophic lateral sclerosis treatment
0,591  0,019  Mood disorders treatment
0,568  0,003  Opioid delta receptor agonist
0,580  0,015  Spasmolytic
0,568  0,005  Muscle relaxant
0,564  0,007  Huntington's disease treatment
0,558  0,004  Antitussive
0,558  0,004  Acetylcholine nicotinic antagonist
0,554  0,003  UGT2B7 substrate
0,544  0,010  UDP-glucuronosyltransferase substrate
0,536  0,002  UGT2B9 substrate
0,548  0,015  Cardiovascular analeptic
0,528  0,002  NMDA receptor subunit 3B antagonist
0,526  0,006  UGT1A3 substrate
0,521  0,009  Sedative
0,493  0,004  Sigma receptor antagonist
0,490  0,005  Cholinergic antagonist
0,489  0,005  Acetylcholine antagonist
0,470  0,004  Neuronal nicotinic receptor antagonist
0,458  0,002  Opioid kappa receptor agonist
0,479  0,035  Cognition disorders treatment
0,442  0,004  Alpha 2a adrenoreceptor antagonist
0,433  0,002  Prolactin inhibitor
0,429  0,005  Antipruritic
0,467  0,045  Antiobesity
0,427  0,019  Psychostimulant
0,459  0,054  Analgesic, non-opioid
0,457  0,052  Transcription factor NF kappa B inhibitor
0,435  0,033  CYP1A2 substrate
0,435  0,036  Antipsychotic
0,449  0,049  Antipruritic, allergic
0,402  0,004  Dopamine D1 antagonist
0,398  0,005  Dopamine agonist
0,392  0,003  Toll-Like receptor 4 antagonist
0,453  0,067  Alzheimer's disease treatment
0,394  0,010  Cholinergic
0,385  0,004  Toll-Like receptor antagonist
0,432  0,052  Immunosuppressant
0,378  0,002  Narcotic antagonist
0,409  0,033  UGT1A9 substrate
0,416  0,042  Respiratory analeptic
0,369  0,003  NMDA 2A receptor antagonist
0,367  0,005  Alpha 2 adrenoreceptor antagonist
0,365  0,004  Constipation treatment
0,379  0,019  Anesthetic general
0,363  0,005  Neuropathy treatment
0,368  0,012  Tyrosine 3 hydroxylase inhibitor
0,393  0,039  Antiepileptic
0,359  0,009  Antidiarrheal
0,365  0,022  5 Hydroxytryptamine uptake stimulant
0,343  0,006  Nav1.1 sodium channel blocker
0,346  0,009  CNS active muscle relaxant
0,336  0,005  Acetylcholine agonist
0,341  0,009  Acetylcholine M1 receptor antagonist
0,421  0,099  Caspase 9 stimulant
0,332  0,013  Alpha adrenoreceptor antagonist
0,332  0,014  Antiischemic, cerebral
0,352  0,037  Cardiodepressant
0,351  0,037  HERG channel blocker
0,354  0,050  Analeptic
0,340  0,039  Potassium channel (Voltage-sensitive) blocker
0,349  0,050  Antiosteoporotic
0,356  0,064  Bone diseases treatment
0,331  0,040  Myocardial infarction treatment
0,300  0,010  Glutamate receptor antagonist
0,298  0,012  Toxic, respiratory center
0,367  0,081  CYP2C19 inhibitor
0,338  0,054  Teratogen
0,287  0,012  Dopamine antagonist
0,324  0,055  Hypoxia-inducible factor 1 alpha inhibitor
0,270  0,012  Dopamine D2 antagonist
0,281  0,025  Contraceptive
0,274  0,019  Interleukin 6 antagonist
0,259  0,005  Dopamine uptake inhibitor
0,261  0,009  Retinopathy treatment
0,314  0,063  Aldehyde oxidase inhibitor
0,258  0,009  Nav1.6 sodium channel blocker
0,253  0,004  Antiprotozoal activity enhancer
0,261  0,013  Alpha 2b adrenoreceptor antagonist
0,249  0,002  Dopamine D5 agonist
0,277  0,031  Antialcoholic
0,271  0,026  Skeletal muscle relaxant
0,389  0,146  Antiinflammatory
0,301  0,061  UGT2B4 substrate
0,307  0,073  Sodium/bile acid cotransporter inhibitor
0,267  0,033  Pneumotoxic
0,277  0,044  Antiparkinsonian, rigidity relieving
0,302  0,070  Cardioprotectant
0,252  0,021  Nav1.2 sodium channel blocker
0,290  0,061  Embryotoxic
0,288  0,061  Antipyretic
0,242  0,016  Acetylcholine muscarinic antagonist
0,273  0,048  Anticonvulsant
0,227  0,005  Dopamine D5 antagonist
0,276  0,055  Potassium channel blocker
0,342  0,123  Calcium channel L-type activator
0,221  0,003  Nicotinic receptor beta4 subunit antagonist
0,294  0,077  NOS3 expression inhibitor
0,304  0,088  Calcium channel activator
0,242  0,030  Antiparkinsonian, tremor relieving
0,258  0,050  Antihypotensive
0,211  0,004  Acetylcholine M3 receptor agonist
0,208  0,005  Acetylcholine muscarinic agonist
0,291  0,088  AR expression inhibitor
0,234  0,032  Anesthetic
0,212  0,010  Antineoplastic alkaloid
0,265  0,066  Superoxide dismutase inhibitor
0,224  0,029  VEGF expression inhibitor
0,217  0,021  Antiadrenergic
0,212  0,021  Adrenaline antagonist
0,204  0,017  Alpha 2c adrenoreceptor antagonist
0,247  0,063  UGT1A6 substrate
0,218  0,036  UGT2B15 substrate
0,272  0,090  Anxiolytic
0,224  0,047  Antipruritic, non-allergic
0,244  0,070  DNA synthesis inhibitor
0,179  0,008  Tocolytic
0,176  0,005  Acetylcholine M1 receptor agonist
0,196  0,026  Adenylate cyclase inhibitor
0,187  0,018  Alpha 1a adrenoreceptor antagonist
0,191  0,022  Alpha 1 adrenoreceptor antagonist
0,185  0,021  Antiemetic
0,204  0,043  Prostate disorders treatment
0,220  0,060  Abortion inducer
0,172  0,012  Alpha adrenoreceptor agonist
0,245  0,088  Chemoprotective
0,162  0,005  Uterine relaxant
0,292  0,136  TNF expression inhibitor
0,197  0,043  Attention deficit/hyperactivity disorder treatment
0,160  0,006  Dopamine D2 agonist
0,170  0,018  Estrogen antagonist
0,260  0,108  CYP3A4 inhibitor
0,213  0,063  Nitric oxide antagonist
0,174  0,025  SULT1A1 substrate
0,205  0,056  UGT1A4 substrate
0,201  0,054  LDLR expression enhancer
0,159  0,013  SULT1E1 substrate
0,191  0,045  UGT2B10 substrate
0,154  0,009  Adrenaline uptake inhibitor
0,164  0,019  Alpha 1b adrenoreceptor antagonist
0,148  0,004  Nicotinic receptor alpha4 subunit antagonist
0,200  0,056  Lipocortins synthesis antagonist
0,229  0,089  Vascular (periferal) disease treatment
0,171  0,035  Adenylate cyclase stimulant
0,205  0,071  Neurotrophic factor enhancer
0,138  0,007  Oxytocin antagonist
0,133  0,003  Prolactin release inhibitor
0,241  0,111  FMO3 substrate
0,159  0,029  Interleukin 8 antagonist
0,174  0,044  SULT1A3 substrate
0,160  0,031  Menstruation disorders treatment
0,167  0,038  Nav1.3 sodium channel blocker
0,181  0,053  Antiviral (Influenza A)
0,226  0,098  Antioxidant
0,143  0,016  Dopamine D3 antagonist
0,143  0,017  5 Hydroxytryptamine uptake inhibitor
0,221  0,095  Hypoglycemic
0,243  0,117  CTGF expression inhibitor
0,171  0,045  Antifungal enhancer
0,237  0,111  Antihypoxic
0,169  0,044  Acetylcholinesterase inhibitor
0,202  0,078  Sensitization
0,141  0,018  Estrogen receptor beta antagonist
0,172  0,050  Antinephritic
0,127  0,005  Nociceptin (N/OFQ) receptor antagonist
0,135  0,017  Alpha 1d adrenoreceptor antagonist
0,227  0,109  Gastrin inhibitor
0,129  0,014  Nicotinic alpha4beta2 receptor antagonist
0,168  0,057  Protein kinase stimulant
0,114  0,003  Dopamine D1 agonist
0,177  0,072  Male reproductive disfunction treatment
0,142  0,037  Choleretic
0,168  0,064  Uterine stimulant
0,203  0,100  NOS2 expression inhibitor
0,163  0,061  NOS3 expression enhancer
0,106  0,006  Acetylcholine M2 receptor agonist
0,184  0,085  Antiviral (Influenza)
0,113  0,015  Postmenopausal disorders treatment
0,213  0,116  5 Hydroxytryptamine 1E antagonist
0,162  0,064  Interferon gamma antagonist
0,105  0,007  5 Hydroxytryptamine 2C agonist
0,104  0,007  SULT2A1 substrate
0,119  0,024  Alpha 2d adrenoreceptor antagonist
0,166  0,072  Urinary incontinence treatment
0,111  0,018  SULT1A2 substrate
0,099  0,007  Lysine-specific demethylase 1A inhibitor
0,096  0,004  Vasopressin 1B antagonist
0,118  0,027  Acetylcholine nicotinic agonist
0,137  0,047  5 Hydroxytryptamine 2B antagonist
0,156  0,067  Antidote
0,109  0,020  Premenstrual syndrome treatment
0,120  0,033  Androgen antagonist
0,099  0,012  Nicotinic receptor alpha7 subunit antagonist
0,094  0,009  Nicotinic alpha3beta2 receptor antagonist
0,154  0,070  Insulin secretagoues
0,101  0,017  Estrogen agonist
0,124  0,041  Chronic obstructive bronchitis treatment
0,118  0,037  UGT2B11 substrate
0,087  0,007  Vasopressin 2 antagonist
0,082  0,002  Vesicular acetylcholine transporter inhibitor
0,148  0,070  Lipid peroxidase inhibitor
0,089  0,012  5 Hydroxytryptamine 2 agonist
0,131  0,054  Contraceptive female
0,124  0,047  GABA C receptor agonist
0,205  0,128  Renal disease treatment
0,099  0,023  CC chemokine 5 receptor agonist
0,225  0,149  Interleukin 2 agonist
0,080  0,004  Alpha 1L adrenoreceptor agonist
0,086  0,010  Vasopressin 1 antagonist
0,088  0,013  Estrogen receptor beta agonist
0,117  0,043  Creatine kinase inhibitor
0,169  0,095  Antimigraine
0,117  0,043  Anabolic
0,078  0,005  Sigma 2 receptor antagonist
0,091  0,018  Androgen agonist
0,086  0,015  Antidiuretic hormone antagonist
0,223  0,151  Vasodilator, peripheral
0,089  0,019  Alpha 2 adrenoreceptor agonist
0,078  0,008  Vasopressin 1A antagonist
0,089  0,020  Alpha 1 adrenoreceptor agonist
0,075  0,006  Acetylcholine M4 receptor agonist
0,236  0,169  Antineoplastic (endocrine cancer)
0,092  0,026  Glycine receptor agonist
0,094  0,030  Sleep apnea treatment
0,113  0,050  Sulfotransferase substrate
0,181  0,121  Vasodilator
0,118  0,060  5 Hydroxytryptamine 2 antagonist
0,062  0,004  Nicotinic alpha3beta4 receptor agonist
0,091  0,034  Estrogen receptor alpha antagonist
0,147  0,090  Prostatic (benign) hyperplasia treatment
0,082  0,026  5 Hydroxytryptamine 2A agonist
0,079  0,026  Acetylcholine M3 receptor antagonist
0,072  0,019  Postcoital contraceptive
0,171  0,119  Antineoplastic enhancer
0,085  0,033  MAP kinase kinase 7 inhibitor
0,093  0,042  Adrenaline agonist
0,110  0,059  DOPA decarboxylase inhibitor
0,062  0,012  Premature ejaculation treatment
0,192  0,143  Flavin-containing monooxygenase substrate
0,090  0,041  Estrogen-related receptor beta agonist
0,062  0,014  Neurokinin 1 antagonist
0,069  0,021  Glycine transporter inhibitor
0,144  0,096  Arachidonic acid antagonist
0,058  0,013  Substance P antagonist
0,141  0,095  Melanin inhibitor
0,058  0,013  Glycine transporter 1 inhibitor
0,059  0,015  Estrogen receptor alpha agonist
0,087  0,044  Somatostatin 1 agonist
0,182  0,139  Radioprotector
0,192  0,149  Antiischemic
0,191  0,149  Prostate cancer treatment
0,084  0,042  Acetylcholine M4 receptor antagonist
0,059  0,019  Nicotinic receptor alpha3 subunit antagonist
0,175  0,135  Antidiabetic symptomatic
0,107  0,068  GABA C receptor antagonist
0,061  0,024  Neurokinin antagonist
0,166  0,132  Urologic disorders treatment
0,130  0,096  Chemopreventive
0,114  0,081  Bipolar disorder treatment
0,049  0,016  Arginase inhibitor
0,059  0,026  Dopamine transporter inhibitor
0,119  0,087  Toll-Like receptor 9 antagonist
0,040  0,008  Nicotinic alpha4beta2 receptor agonist
0,047  0,015  5 Hydroxytryptamine 2B agonist
0,149  0,118  P-glycoprotein inhibitor
0,118  0,087  Bone formation stimulant
0,103  0,072  5 Hydroxytryptamine 3A agonist
0,107  0,077  Anesthetic local
0,077  0,048  Cushing's syndrome treatment
0,047  0,018  Phenylethanolamine N methyltransferase inhibitor
0,172  0,143  DNA damaging
0,103  0,076  5 Hydroxytryptamine antagonist
0,132  0,106  Ca2+-transporting ATPase inhibitor
0,063  0,037  Acetylcholine M5 receptor antagonist
0,053  0,027  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,165  0,139  Cytostatic
0,078  0,052  Na+ K+ transporting ATPase inhibitor
0,083  0,059  5 Hydroxytryptamine 2C antagonist
0,165  0,143  Immunostimulant
0,056  0,035  NMDA 2B receptor antagonist
0,078  0,059  Glycine receptor antagonist
0,162  0,143  Tumour necrosis factor alpha release inhibitor
0,113  0,096  Antihelmintic (Trematoda)
0,061  0,044  Heme oxygenase stimulant
0,023  0,005  Nicotinic alpha4 receptor agonist
0,058  0,043  Aromatase inhibitor
0,031  0,016  Sigma 1 receptor antagonist
0,032  0,019  Dipeptidyl peptidase I inhibitor
0,076  0,062  5 Hydroxytryptamine 2A antagonist
0,054  0,041  Nicotinic neuronal receptor agonist
0,025  0,012  Nociceptin (N/OFQ) receptor agonist
0,051  0,041  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,183  0,174  Hepatic disorders treatment
0,119  0,111  Genotoxic
0,032  0,024  Estrogen-related receptor beta antagonist
0,089  0,080  Tourette's syndrome treatment
0,082  0,076  Sodium/hydrogen exchanger 5 inhibitor
0,147  0,142  CYP2B6 inhibitor
0,096  0,093  Cholesterol synthesis inhibitor
0,242  0,239  5 Hydroxytryptamine release inhibitor
0,062  0,061  Antihemophilic
0,115  0,115  Farnesoid X receptor antagonist
0,030  0,029  Progesterone antagonist

